Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
International Journal of Dermatology|May 13, 2017
Tattooing and psoriasis: a case series and review of the literatureNicolas Kluger, Eric Estève, Sébastien Fouéré, et al.
Annales De Pathologie|January 31, 2004
[Keratoacanthoma: two cases with intravascular spread]Annabel Gottfarstein-Maruani, Patrick Michenet, Rémy Kerdraon, et al.
Presse Medicale (Paris, France : 1983)|November 12, 2013
[Interest of emergency dermatological consultation in a regional hospital]Adeline Wakosa, Aude Roussel, Marion Delaplace, et al.
Muscle & Nerve|April 25, 2026
Asynchrony Related to Mechanical Ventilation Exacerbates Diaphragm Dysfunction in a Mouse Model of Duchenne Muscular DystrophyMohamad Yehya, Haikel Dridi, Eric Estève, et al.
The Journal of Biological Chemistry|February 15, 2003
Maurocalcine and peptide A stabilize distinct subconductance states of ryanodine receptor type 1, revealing a proportional gating mechanismLili Chen, Eric Estève, Jean-Marc Sabatier, et al.
Oncotarget|July 24, 2018
Bone mineral density and microarchitecture linkages with micro- and macro-vascular impairments at the hand in systemic sclerosis: an HRpQCT studyLucie Atlan, Nada Ibrahim-Nasser, Antoine Valery, et al.
The Journal of General Physiology|May 19, 2010
A malignant hyperthermia-inducing mutation in RYR1 (R163C): consequent alterations in the functional properties of DHPR channelsRoger A Bannister, Eric Estève, José M Eltit, et al.
The Journal of Biological Chemistry|December 14, 2004
Maurocalcine and domain A of the II-III loop of the dihydropyridine receptor Cav 1.1 subunit share common binding sites on the skeletal ryanodine receptorXavier Altafaj, Weijun Cheng, Eric Estève, et al.
The Journal of General Physiology|May 19, 2010
A malignant hyperthermia-inducing mutation in RYR1 (R163C): alterations in Ca2+ entry, release, and retrograde signaling to the DHPREric Estève, José M Eltit, Roger A Bannister, et al.
Archives of Dermatology|September 21, 2005
Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective studyJulie de Quatrebarbes, Eric Estève, Martine Bagot, et al.
Pageof 4